Newsroom | 24891 results

Sorted by: Latest

Hospitals
-

ImmunityBio Announces Houston’s Michael E. DeBakey VA Medical Center Is Among the First VA Hospitals to Administer ANKTIVA® to Bladder Cancer Patients

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the Michael E. DeBakey Department of Veterans Affairs (VA) Medical Center in Houston recently became the first VA hospital in the Houston region and one of the first in the U.S. to provide treatment with ANKTIVA® (nogapendekin alfa inbakicept-pmln) to a veteran with bladder cancer. ANKTIVA, the first of its kind immune-boosting, lymphocyte stimulating agent, is approved by th...
-

Sonida Senior Living Announces Second Quarter 2025 Results

DALLAS--(BUSINESS WIRE)--Sonida Senior Living, Inc. (the “Company,” “Sonida,” “we,” “our,” or “us”) (NYSE: SNDA), a leading owner, operator and investor of senior housing communities, today announced its results for the second quarter ended June 30, 2025. “Sonida delivered strong total portfolio community NOI in the second quarter propelled by healthy rent rate growth and effective integration of recently acquired communities,” said Brandon Ribar, President and CEO. “The Company made foundation...
-

Concentra Expands to Union City, Georgia

ADDISON, Texas--(BUSINESS WIRE)--Concentra®, (NYSE: CON) the nation’s leader in occupational medicine, today announced the opening of a new medical center in Union City, Georgia. The medical center, Concentra Union City, is conveniently located at 6851 Shannon Parkway, Suite 5, Union City, Georgia 30291. “Concentra Union City marks our continued expansion in the Atlanta area,” said Janet Cobb, MD, senior vice president of Concentra medical operations. “We look forward to serving Atlanta employe...
-

Community Health Systems, Inc. Announces Early Tender Results for Its 5.625% Senior Secured Notes Due 2027

FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (the “Company”) (NYSE: CYH) announced today the early tender results of the previously announced cash tender offer (the “Tender Offer”) by its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), to purchase any and all of the Issuer’s outstanding 5.625% Senior Secured Notes due 2027 (the “2027 Notes”), on the terms and subject to the conditions set forth in the Offer to Purchase, dated July 28, 2025, as ame...
-

Owens & Minor Reports Second Quarter 2025 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2025. In connection with a likely sale of the Company’s Products & Healthcare Services segment, the results herein, unless otherwise noted, reflect the Company’s continuing operations which primarily represent what was previously the Patient Direct segment and certain functional operations. “We are in the final stages of our robust process for the divest...
-

NanoVibronix Announces Reverse Stock Split

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic devices, today announced that it intends to effect a reverse stock split of its common stock, par value $0.001 per share (the “common stock”) at a ratio of 1 post-split share for every 10 pre-split shares. The reverse stock split will become effective at 4:05 p.m. ET on Monday, August 11, 2025. The Company’s common stock will c...
-

NHC Reports Second Quarter 2025 Earnings

MURFREESBORO, Tenn.--(BUSINESS WIRE)--National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues for the quarter ended June 30, 2025 totaled $374,910,000 compared to $300,658,000 for the quarter ended June 30, 2024, an increase of 24.7%. The increase in net operating revenues for the second quarter of 2025 compared to the second quarter of 2024 was due to an 9.6% increase in same-facility net opera...
-

TruBridge Announces Second Quarter 2025 Results

MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, today announced financial results for the second quarter and six months ended June 30, 2025. Second Quarter 2025 Highlights* All comparisons are to the quarter ended June 30, 2024, unless otherwise noted Total bookings of $25.6 million compared to $23.3 million Total revenue of $85.7 million compared to $85.6 million Recurring revenue represented 95% of total revenue Financial Health revenue of $54.3...
-

HistoSonics宣布被顶级投资者联盟以22.5亿美元收购

明尼阿波利斯--(BUSINESS WIRE)--(美国商业资讯)-- Edison®组织摧毁术系统及新型组织摧毁术治疗平台的研发企业HistoSonics今日宣布,由一批全球知名的私人和公共投资者组成的联盟将以管理层主导的方式收购其多数股权,投资方包括K5 Global、Bezos Expeditions、Wellington Management以及其他新老投资者。此次交易对HistoSonics的估值约为22.5亿美元,将助力公司加速Edison系统在新临床适应症及全球市场的增长。 HistoSonics将继续由总裁兼首席执行官Mike Blue及其管理团队领导。交易完成后,Blue先生还将担任董事会主席一职。 Blue先生表示:“作为一家公司,我们始终专注于速度、规模,以及为患者提供比现有方案更优选择的迫切使命。这批新合作伙伴支持那些定义品类、变革整个行业的企业。他们的支持将为我们注入动力,加速发展势头,拓展至新的临床适应症,惠及全球更多急需我们突破性疗法的患者。” HistoSonics计划在初始聚焦的肝肿瘤之外,将业务扩展至肾、胰腺和前列腺肿瘤适应症,其长期愿景是让组织摧毁...
-

HistoSonics宣布被頂尖投資人聯盟以22.5億美元收購

明尼亞波里斯--(BUSINESS WIRE)--(美國商業資訊)-- Edison®組織摧毀術系統及新型組織摧毀術治療平台的研發企業HistoSonics今日宣布,由一批全球知名的私人和公共投資人組成的聯盟將以管理層主導的方式收購其多數股權,投資方包括K5 Global、Bezos Expeditions、Wellington Management以及其他新投資人和現有投資人。此次交易對HistoSonics的估值約為22.5億美元,將協助公司加快Edison系統在新臨床適應症及全球市場的成長。 HistoSonics將繼續由總裁兼執行長Mike Blue及其管理團隊領導。交易完成後,Blue先生還將擔任董事長一職。 Blue先生表示:「身為一家公司,我們始終專注於速度、規模,以及為病患提供比現有方案更優選擇的迫切使命。這批新合作夥伴支援那些定義品類、變革整個產業的企業。他們的支援將為我們注入動力,加大發展動力,擴大至新的臨床適應症,嘉惠全球更多亟需我們突破性療法的病患。」 HistoSonics計畫在初始聚焦的肝腫瘤之外,將業務擴充至腎、胰腺和攝護腺腫瘤適應症,其長期願景是讓組織摧...